Literature DB >> 30190948

Limitations of screening for hepatocellular carcinoma.

Morris Sherman1.   

Abstract

Entities:  

Year:  2014        PMID： 30190948      PMCID： PMC6096434          DOI： 10.2217/hep.13.22

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  23 in total

1.  Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.

Authors:  M J Tong; L M Blatt; V W Kao
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

2.  Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.

Authors:  Alessandro Furlan; Daniele Marin; Paolo Cabassa; Adele Taibbi; Elena Brunelli; Francesco Agnello; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Eur J Radiol       Date:  2011-09-08       Impact factor: 3.528

3.  Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

Authors:  Margarita Sala; Josep M Llovet; Ramon Vilana; Lluís Bianchi; Manel Solé; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

4.  Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Authors:  A Singal; M L Volk; A Waljee; R Salgia; P Higgins; M A M Rogers; J A Marrero
Journal:  Aliment Pharmacol Ther       Date:  2009-04-08       Impact factor: 8.171

5.  Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

Authors:  Fabio Farinati; Dario Marino; Massimo De Giorgio; Anna Baldan; Maria Cantarini; Carmela Cursaro; Gianludovico Rapaccini; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Mauro Bernardi; Franco Trevisani
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

6.  Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.

Authors:  Richard K Sterling; Lennox Jeffers; Fredric Gordon; Alan P Venook; K Rajender Reddy; Shinji Satomura; Futoshi Kanke; Myron E Schwartz; Morris Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-17       Impact factor: 11.382

7.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

8.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

9.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  1 in total

1.  Incidentalomas are associated with an increase in liver transplantation in patients with cirrhosis: a single-center retrospective study.

Authors:  Pedro Cortés; Hassan M Ghoz; Fernando Stancampiano; Mohamed Omer; Balkishan Malviya; Andrew W Bowman; William C Palmer
Journal:  BMC Gastroenterol       Date:  2022-07-10       Impact factor: 2.847
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.